Safety profile of recombinant factor VIIa.
D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D001779:Blood Coagulation Factors / Q000502:physiology; D016063:Blood Loss, Surgical / Q000517:prevention & control; D003257:Consumer Product Safety / Q000592:standards*; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced / Q000503:physiopathology; D005167:Factor VII / Q000009:adverse effects* / Q000592:standards* / Q000627:therapeutic use; D015942:Factor VIIa; D006467:Hemophilia A / Q000188:drug therapy; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects; D019106:Postoperative Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D011994:Recombinant Proteins / Q000009:adverse effects* / Q000592:standards* / Q000627:therapeutic use; D012307:Risk Factors; D018805:Sepsis / Q000139:chemically induced; D013927:Thrombosis / Q000139:chemically induced; D014947:Wounds and Injuries / Q000150:complications / Q000188:drug therapy
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa